Anti-PAH monoclonal antibody

Pre-made anti-PAH monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PAH/PAH products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T76213-Ab-1/ GM-Tg-hg-T76213-Ab-2Anti-Human PAH monoclonal antibodyHuman
GM-Tg-rg-T76213-Ab-1/ GM-Tg-rg-T76213-Ab-2Anti-Rat PAH monoclonal antibodyRat
GM-Tg-mg-T76213-Ab-1/ GM-Tg-mg-T76213-Ab-2Anti-Mouse PAH monoclonal antibodyMouse
GM-Tg-cynog-T76213-Ab-1/ GM-Tg-cynog-T76213-Ab-2Anti-Cynomolgus/ Rhesus macaque PAH monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T76213-Ab-1/ GM-Tg-felg-T76213-Ab-2Anti-Feline PAH monoclonal antibodyFeline
GM-Tg-cang-T76213-Ab-1/ GM-Tg-cang-T76213-Ab-2Anti-Canine PAH monoclonal antibodyCanine
GM-Tg-bovg-T76213-Ab-1/ GM-Tg-bovg-T76213-Ab-2Anti-Bovine PAH monoclonal antibodyBovine
GM-Tg-equg-T76213-Ab-1/ GM-Tg-equg-T76213-Ab-2Anti-Equine PAH monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T76213-Ab-1/ GM-Tg-hg-T76213-Ab-2; GM-Tg-rg-T76213-Ab-1/ GM-Tg-rg-T76213-Ab-2;
GM-Tg-mg-T76213-Ab-1/ GM-Tg-mg-T76213-Ab-2; GM-Tg-cynog-T76213-Ab-1/ GM-Tg-cynog-T76213-Ab-2;
GM-Tg-felg-T76213-Ab-1/ GM-Tg-felg-T76213-Ab-2; GM-Tg-cang-T76213-Ab-1/ GM-Tg-cang-T76213-Ab-2;
GM-Tg-bovg-T76213-Ab-1/ GM-Tg-bovg-T76213-Ab-2; GM-Tg-equg-T76213-Ab-1/ GM-Tg-equg-T76213-Ab-2
Products NameAnti-PAH monoclonal antibody
Formatmab
Target NamePAH
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PAH monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T76213-Ag-1Recombinant multi-species PH4H/ PAH/ PH protein
    ORF Viral VectorpGMLP003716human PAH Lentivirus plasmid
    ORF Viral VectorvGMLP003716human PAH Lentivirus particle
    ORF Viral VectorpGMLPm001594mouse Pah Lentivirus plasmid
    ORF Viral VectorvGMLPm001594mouse Pah Lentivirus particle


    Target information

    Target IDGM-T76213
    Target NamePAH
    Gene ID5053,18478,24616,698696,475446,101081741,510583,100053361
    Gene Symbol and SynonymsPAH,PH,PKU,PKU1
    Uniprot AccessionP00439,P04176,Q2KIH7
    Uniprot Entry NamePH4H_HUMAN,PH4H_RAT,PH4H_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000171759
    Target ClassificationN/A

    The target: PAH, gene name: PAH, also named as PH, PKU, PKU1. This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.